thenewsfacts.com
  • Home
  • Latest News
  • Trending News
  • Entertainment
  • Technology
  • Sports
  • Business
  • Health
thenewsfacts.comthenewsfacts.com
Font ResizerAa
Search
  • Home
  • Latest News
  • Trending News
  • Entertainment
  • Technology
  • Sports
  • Business
  • Health
Follow US
© thenewsfacts : All Rights Reserved.

Home » COVAXIN Covishield Cocktail new ICMR study claims better immunogenicity

COVID Vaccines

COVAXIN Covishield Cocktail new ICMR study claims better immunogenicity

TheNewsFacts
Last updated: August 8, 2021 3:25 pm
TheNewsFacts
Share
COVAXIN Covishield Cocktail new ICMR study claims better immunogenicity
SHARE

A new study on COVID-19 Vaccine Cocktail by the Pune-based National Institute of Virology (NIV) claims that recipients who received a mix of Covishield and Covaxin doses have greater immunogenicity than two doses of the same vaccine.

Contents
COVAXIN Covishield Cocktail Deliver Better Immunogencity – New ICMR StudyExperts View on Mixing COVAXIN , Covishield – Dr. Randeep Guleria

ICMR-National Institute of Virology Pune which conducted the study on 18 people data is yet to be peer-reviewed. The Study compared the safety and immunogenicity profile of the individuals against those who received either Covishield or Covaxin (n=40 in each group).

COVAXIN Covishield Cocktail Deliver Better Immunogencity – New ICMR Study

The finding also suggests that immunization with a combination of two different platforms- an adenovirus vector platform-based vaccine (Covishield) followed by an inactivated whole virus vaccine (Covaxin) was not only safe but also elicited better immunogenicity.

ICMR study shows #COVAXIN is effective in Delta, Delta AY.1 and B.1.617.3 variants. Article is available at https://t.co/QtrY3zDXUo@MoHFW_INDIA @DeptHealthRes @PIB_India @COVIDNewsByMIB #LargestVaccineDrive #Unite2FightCorona #IndiaFightsCorona #COVID19 #DeltaVariant pic.twitter.com/O52oKSLl1T

— ICMR (@ICMRDELHI) August 2, 2021

Some scientists say that mixing vaccines could make the fight against Covid-19 stronger as mixing doses of different vaccines results in production of a more potent immune response against Covid-19.

Dr Chandrakant Lahariya, a senior vaccinologist told The Indian Express that mixing vaccines could prove more beneficial in case of viral vector vaccines like Covishield. Dr Lahariya explained that the effectiveness of such vaccines reduces substantially in successive doses as the body starts developing antibodies even against the adenovirus used by the vaccine.

Experts View on Mixing COVAXIN , Covishield – Dr. Randeep Guleria

Experts View on Mixing of COVAXIN and Covishield

AIIMS chief Dr Randeep Guleria seconds the move but have some reservations. He said mixing Covid vaccines is a “definite possibility” but more information is needed before a decision can be taken. He added that though we don’t know which combination is better at this time, but initial studies suggest it may be an option.

Amid new variants reported across globe, scientists have highlighted that mixing vaccines could develop a wider and broad-range immune response against different mutations of the virus. Some experts have also suggested that mixing vaccines will be beneficial in fighting shortage as the mixing doses could ease the availability.

Share This Article
Twitter Email Copy Link Print
Previous Article 7 Straight Basketball Olympic titles for the US Women - Olympics 7 Straight Basketball Olympic titles for the US Women – New Facts
Next Article Worlds Smallest, Low Priced 3.3 inch display Smartphone launched Worlds Smallest, Low Priced 3.3 inch display Smartphone launched

Your Trusted Source for Accurate and Timely Updates!

We're committed to providing accurate and unbiased news as it unfolds, earning the trust of a large audience. Stay informed with our news updates on the latest events and trends, keeping you ahead of the curve.
FacebookLike
TwitterFollow
InstagramFollow

Popular Posts

COVAXIN Booster Neutralizes, COVID-19 Omicron and Delta Variants – New Study

COVAXIN Booster Shown to Neutralize Both Omicron and Delta Variants of SARS-CoV-2. Bharat Biotech announced…

By TheNewsFacts

Game Changer Review: Action-Packed Yet Aimless

January 10, 2025: Writer-director Shankar’s first Telugu film, Game Changer, carries the weight of high…

By TheNewsFacts

IndiaJoy 2021 Inspires Over 30 Big VFX Global Experts

IndiaJoy 2021 has a big focus on Visual Effects, trends and advancements around it. VFX…

By TheNewsFacts

You Might Also Like

Covaxin BHU Study
COVID VaccinesLatest News

Covaxin BHU Study: BB Points Flaws in Data Points, Backs Strong Safety Track Record

By NewsFacts Bureau
COVAXIN
COVID Vaccines

COVAXIN production to be demand-driven, says Bharat Biotech

By TheNewsFacts
iNCOVACC: Bharat Biotech Reveals World's 1st Nasal COVID Vaccine Price
COVID Vaccines

iNCOVACC: Bharat Biotech Reveals World’s 1st Nasal COVID Vaccine Price

By TheNewsFacts
Bharat Biotech iNCOVACC Vaccine priced ₹800 in CoWIN, ₹325 for the Govt Supplies, Rollout in January 2023
COVID Vaccines

Bharat Biotech iNCOVACC Vaccine priced ₹800 in CoWIN, ₹325 for the Govt Supplies, Rollout in January 2023

By TheNewsFacts
thenewsfacts thenewsfacts

About US


TheNewsFacts: Brings you the interesting facts, news facts and updates from India an the world across politics, tech, entertainment, business, tending, and more. We deliver what you love to read.
Top Categories
  • Latest News
  • Trending News
  • Paris Olympics 2024
  • Sports
  • Entertainment
  • Business
  • Technology
Usefull Links
  • About The News Facts
  • Latest News
  • Privacy Policy
  • Editorial Policy
  • Disclaimer
  • Contact Us
Follow us
Facebook Twitter Instagram

© thenewsfacts. All Rights Reserved.

Welcome Back!

Sign in to your account

Lost your password?